Proteros: Arbutus Biopharma, X-Chem and Proteros biostructures Enter into a Pan-Coronavirus Discovery Research and License Agreement
Collaboration formed to accelerate the discovery of novel oral inhibitors targeting the SARS-CoV-2 nsp5 main protease for the treatment of COVID-19 and potential future coronavirus outbreaks
Read full article »
Proteros is a Germany-based CRO that provides services such as drug discovery and biophysical testing for sectors including biotechnology and pharmaceuticals.
Read more